| Product Code: ETC11383758 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India anti-tuberculosis therapeutics market import shipment witnessed a significant decline with a CAGR of -82.9% from 2020 to 2024. The growth rate between 2023 and 2024 further plummeted by -98.6%, indicating a rapid contraction. The market has experienced a substantial slowdown, showing a clear downward trajectory and loss of momentum.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Anti Tuberculosis Therapeutics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Anti Tuberculosis Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 India Anti Tuberculosis Therapeutics Market - Industry Life Cycle |
3.4 India Anti Tuberculosis Therapeutics Market - Porter's Five Forces |
3.5 India Anti Tuberculosis Therapeutics Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 India Anti Tuberculosis Therapeutics Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 India Anti Tuberculosis Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Anti Tuberculosis Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of tuberculosis in India |
4.2.2 Government initiatives to control tuberculosis |
4.2.3 Growing awareness about the importance of early diagnosis and treatment |
4.3 Market Restraints |
4.3.1 High treatment cost and limited access to healthcare facilities |
4.3.2 Rising cases of drug-resistant tuberculosis |
4.3.3 Stigma associated with tuberculosis leading to delayed diagnosis and treatment |
5 India Anti Tuberculosis Therapeutics Market Trends |
6 India Anti Tuberculosis Therapeutics Market, By Types |
6.1 India Anti Tuberculosis Therapeutics Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 India Anti Tuberculosis Therapeutics Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 India Anti Tuberculosis Therapeutics Market Revenues & Volume, By First-Line Anti-TB Drugs, 2021 - 2031F |
6.1.4 India Anti Tuberculosis Therapeutics Market Revenues & Volume, By Second-Line Anti-TB Drugs, 2021 - 2031F |
6.1.5 India Anti Tuberculosis Therapeutics Market Revenues & Volume, By Combination Drugs, 2021 - 2031F |
6.2 India Anti Tuberculosis Therapeutics Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 India Anti Tuberculosis Therapeutics Market Revenues & Volume, By Pulmonary Tuberculosis, 2021 - 2031F |
6.2.3 India Anti Tuberculosis Therapeutics Market Revenues & Volume, By Extrapulmonary Tuberculosis, 2021 - 2031F |
6.3 India Anti Tuberculosis Therapeutics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Anti Tuberculosis Therapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 India Anti Tuberculosis Therapeutics Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 India Anti Tuberculosis Therapeutics Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.3.5 India Anti Tuberculosis Therapeutics Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
7 India Anti Tuberculosis Therapeutics Market Import-Export Trade Statistics |
7.1 India Anti Tuberculosis Therapeutics Market Export to Major Countries |
7.2 India Anti Tuberculosis Therapeutics Market Imports from Major Countries |
8 India Anti Tuberculosis Therapeutics Market Key Performance Indicators |
8.1 Number of patients completing TB treatment successfully |
8.2 Percentage of population covered under government TB control programs |
8.3 Adoption rate of new and more effective anti-tuberculosis drugs |
8.4 Percentage reduction in TB-related mortality rate |
8.5 Number of healthcare facilities offering TB diagnosis and treatment services |
9 India Anti Tuberculosis Therapeutics Market - Opportunity Assessment |
9.1 India Anti Tuberculosis Therapeutics Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 India Anti Tuberculosis Therapeutics Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 India Anti Tuberculosis Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Anti Tuberculosis Therapeutics Market - Competitive Landscape |
10.1 India Anti Tuberculosis Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 India Anti Tuberculosis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here